NO20042870L - Kombinasjon av en selektiv PDE4-inhibitor og en adrenerg beta-2-reseptorantagonist - Google Patents

Kombinasjon av en selektiv PDE4-inhibitor og en adrenerg beta-2-reseptorantagonist

Info

Publication number
NO20042870L
NO20042870L NO20042870A NO20042870A NO20042870L NO 20042870 L NO20042870 L NO 20042870L NO 20042870 A NO20042870 A NO 20042870A NO 20042870 A NO20042870 A NO 20042870A NO 20042870 L NO20042870 L NO 20042870L
Authority
NO
Norway
Prior art keywords
combination
receptor antagonist
pde4 inhibitor
adrenergic beta
selective pde4
Prior art date
Application number
NO20042870A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Yeadon
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO20042870L publication Critical patent/NO20042870L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
NO20042870A 2001-12-07 2004-07-06 Kombinasjon av en selektiv PDE4-inhibitor og en adrenerg beta-2-reseptorantagonist NO20042870L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0129395.0A GB0129395D0 (en) 2001-12-07 2001-12-07 Pharmaceutical combination
PCT/IB2002/004922 WO2003047578A1 (en) 2001-12-07 2002-11-22 Combination of a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist

Publications (1)

Publication Number Publication Date
NO20042870L true NO20042870L (no) 2004-07-06

Family

ID=9927247

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042870A NO20042870L (no) 2001-12-07 2004-07-06 Kombinasjon av en selektiv PDE4-inhibitor og en adrenerg beta-2-reseptorantagonist

Country Status (33)

Country Link
US (2) US20030119862A1 (is)
EP (1) EP1455783A1 (is)
JP (1) JP2005511657A (is)
KR (1) KR20050044699A (is)
CN (1) CN1599609A (is)
AP (1) AP2004003054A0 (is)
AR (1) AR037712A1 (is)
AU (1) AU2002353255A1 (is)
BR (1) BR0214776A (is)
CA (1) CA2468676A1 (is)
CO (1) CO5590899A2 (is)
EA (1) EA200400640A1 (is)
EC (1) ECSP045142A (is)
GB (1) GB0129395D0 (is)
HN (1) HN2002000356A (is)
HR (1) HRP20040515A2 (is)
HU (1) HUP0402546A3 (is)
IL (1) IL162098A0 (is)
IS (1) IS7277A (is)
MA (1) MA27152A1 (is)
MX (1) MXPA04004930A (is)
NO (1) NO20042870L (is)
NZ (1) NZ533030A (is)
OA (1) OA12736A (is)
PA (1) PA8560601A1 (is)
PE (1) PE20031066A1 (is)
PL (1) PL370770A1 (is)
SV (1) SV2004001430A (is)
TN (1) TNSN04102A1 (is)
TW (1) TWI242433B (is)
UY (1) UY27564A1 (is)
WO (1) WO2003047578A1 (is)
ZA (1) ZA200403905B (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
DE10360954B3 (de) * 2003-12-23 2005-08-18 Esparma Gmbh Verwendung von Silibinin, dessen Salzen und/oder dessen Prodrugs zusammen mit α-Liponsäure zur Behandlung chronisch obstruktiver Lungenerkrankungen
WO2012098495A1 (en) * 2011-01-19 2012-07-26 Glenmark Pharmaceuticals Sa Pharmaceutical composition that includes revamilast and a beta-2 agonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0837860T3 (da) * 1995-06-06 2002-05-27 Pfizer Tricykliske 5,6-dihydro-9H-pyrazolo[3,4-c]-1,2,4-triazolo-[4,3-alfa]pyridiner
BR9913152A (pt) * 1998-08-26 2001-05-15 Smithkline Beecham Corp Terapias para tratamento de doenças pulmonares
KR100701904B1 (ko) * 1999-08-21 2007-04-02 알타나 파마 아게 Pde 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합

Also Published As

Publication number Publication date
SV2004001430A (es) 2004-02-24
OA12736A (en) 2006-06-29
GB0129395D0 (en) 2002-01-30
HRP20040515A2 (en) 2004-10-31
ZA200403905B (en) 2005-06-22
IL162098A0 (en) 2005-11-20
CO5590899A2 (es) 2005-12-30
HN2002000356A (es) 2003-02-21
WO2003047578A1 (en) 2003-06-12
TWI242433B (en) 2005-11-01
CN1599609A (zh) 2005-03-23
AR037712A1 (es) 2004-12-01
EA200400640A1 (ru) 2004-12-30
EP1455783A1 (en) 2004-09-15
TNSN04102A1 (fr) 2006-06-01
CA2468676A1 (en) 2003-06-12
NZ533030A (en) 2007-03-30
UY27564A1 (es) 2003-07-31
PA8560601A1 (es) 2005-02-04
AU2002353255A1 (en) 2003-06-17
HUP0402546A2 (hu) 2005-04-28
US20040167153A1 (en) 2004-08-26
KR20050044699A (ko) 2005-05-12
ECSP045142A (es) 2004-07-23
PL370770A1 (en) 2005-05-30
MA27152A1 (fr) 2005-01-03
BR0214776A (pt) 2004-11-09
JP2005511657A (ja) 2005-04-28
TW200300678A (en) 2003-06-16
AP2004003054A0 (en) 2004-06-30
IS7277A (is) 2004-05-21
HUP0402546A3 (en) 2008-04-28
PE20031066A1 (es) 2003-12-24
US20030119862A1 (en) 2003-06-26
MXPA04004930A (es) 2005-04-08

Similar Documents

Publication Publication Date Title
NO20035697D0 (no) 5-HT-reseptor-ligander og anvendelser derav
DE60103974D1 (de) Gyrase-inhibitoren und ihre verwendung
NO20020225L (no) Ekspanderbare anordninger
NO20032668L (no) Gyraseinhibitorer og anvendelser derav
NO20021195L (no) Rörfört fraktureringsverktöy og fremgangsmåte
NO20040248L (no) Blandede metallocenkatalysatorsystemer som inneholder en darlig komonomerinkorporering og en god konomoneringkorporering
NO20023639L (no) Fremgangsmåte og anordninger for å klargjöre brönner
DE60207321D1 (de) Verschlussvorrichtung und -methode
DE60234030D1 (de) Kommunikationsvorrichtung und -verfahren
NO20041648L (no) Borebronner og borefluider
NO20035174L (no) Radialt utvidbart r degree relement med underst degree ttet endeparti
DE60218397D1 (de) Kommunikationsgerät und -verfahren
NO20024075L (no) Borefluid, anordning og fremgangsmåte
DE60238229D1 (de) Sendevorrichtung und sendeverfahren
NO20024732D0 (no) Ny kombinasjon av en betablokker og et kolesterolsenkende middel
NO20023843L (no) Skumanordning og fremgangsmåte
NO20042870L (no) Kombinasjon av en selektiv PDE4-inhibitor og en adrenerg beta-2-reseptorantagonist
NO20031997L (no) CRF-reseptor-antagonist og metoder relatert dertil
DE60134579D1 (de) Kommunikationsverfahren und kommunikationseinrichtung
IS2536B (is) Lyfjablanda úr PDE4 eða PDE3/4 tálma og histamínviðtakamótlyfi
NO20021669D0 (no) Fluidfyllt borerörsplugg
NO20023144D0 (no) Kompleks omfattende OCIF og polysakkarid
PT1448566E (pt) Antagonistas do receptor quimioquina e metodos de utilizacao do mesmo
DE60222015D1 (de) Ccr-3-rezeptorantagonisten vii
AU2003284361A8 (en) Visualizing patterns of behavior of abtracted network elements

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application